County of Los Angeles Department of Public Health, Substance Abuse Prevention and Control Program

With

UCLA Integrated Substance Abuse Programs, and the
Pacific Southwest Addiction Technology Transfer Center

Presents a Special Training on
Marijuana-Care Considerations: Post-Legalization

Friday, December 15, 2017, 10:00 a.m. – 1:15 p.m.
County of Los Angeles Dept. of Public Health, Substance Abuse Prevention and Control
Lecture Hall-Building A-7, 1000 South Fremont Avenue, Alhambra, CA 91803

Featured Presenters:

Larissa Mooney, MD, University of California, Los Angeles, Integrated Substance Abuse Programs
Joseph Nicchitta, Los Angeles County Office of Cannabis Management

Panelists:

Yolanda Cordero, MPA, Los Angeles County Department of Public Health, Substance Abuse
Prevention and Control
Tim Duenas, MPA, Los Angeles County Department of Public Health, Substance Abuse Prevention and Control
David Hindman, PhD, Los Angeles County Department of Public Health, Substance Abuse Prevention and Control
Yanira Lima, MPH, MHM, Los Angeles County Department of Public Health, Substance Abuse
Prevention and Control
Gary Tsai, MD, Los Angeles County Department of Public Health, Substance Abuse Prevention and Control

Cannabis legalization in California has raised many questions and concerns regarding the effect that it will have on the marijuana industry and the general population. This lecture will begin with an overview of the Cannabis Laws in California that have been developed throughout the years. There will be discussion of various issues that have occurred during the time of pre-legalization, and how these issues will change after the legalization of cannabis. How will ‘Medical Marijuana’ and ‘Recreational Marijuana’ be distinguished? How will marijuana be regulated post-legalization? These types of questions will be explored, along with many others pertaining to Cannabis legalization.
 
The afternoon presentation will review current knowledge of psychosocial and health effects of cannabis use. Functional outcomes associated with cannabis use including school and work performance, medical conditions, cognition, quality of life, and psychiatric symptoms will be discussed. Co-occurring psychiatric disorders observed in cannabis users will be reviewed, including a discussion of early cannabis use as a risk factor for development of psychosis. Evidence-based behavioral and pharmacological treatment approaches for cannabis use disorder will also be outlined.
 
The lecture will conclude with a panel discussion focusing on prevention interventions, clinical treatment interventions, and substance use disorder treatment system of care.
 

By the conclusion of the lecture, participants should be able to:

  1. Utilize DSM5 to identify two key differences between recreational use and a diagnosable Cannabis Use Disorder.
     
  2. Describe one major public health and safety concern related to marijuana use.
     
  3. Discuss anticipated changes in the prevalence and incidence of marijuana use pre- and postlegalization.
     
  4. Recognize and assess common medical and psychiatric co-morbidities associated with Cannabis Use Disorders.
     
  5. Identify and select at least one evidenced based treatment approach for Cannabis Use Disorder.

Continuing Education

 
The training course meets the qualifications for the provision of three (3.0) continuing education credits/contact hours (CEs/CEHs). UCLA ISAP is approved by the California Association of Marriage and Family Therapists to sponsor continuing education for LMFTs, LCSWs, LPCCs, and/or LEPs (Provider #64812). UCLA ISAP maintains responsibility for this program/course and its content. Course meets the qualifications for three (3.0) hours of continuing education credit for LMFTs, LCSWs, LPCCS, and LEPs as required by the California Board of Behavioral Sciences. UCLA ISAP is also an approved provider of continuing education for RADTs I/II, CADCs-CASs, CADCs I/II, CADCs-CSs, and LAADCs (CCAPP, #2N-00-445-1117), CATCs (ACCBC/CAADE, #CP 20 872 C 0819), and CAODCs (CADTP, #151). CE credit will be awarded at the conclusion of the training. Partial credit will not be available for those participants who arrive late or leave early.
 
This activity has been planned and implemented in accordance with the accreditation requirements and policies of IMQ/CMA Institute for Medical Quality, a subsidiary of the California Medical Association, through the joint providership of L.A. Care Health Plan and L.A. County Department of Public Health, Substance Abuse Prevention and Control. L.A. Care Health Plan is accredited by the IMQ/CMA to provide continuing medical education for physicians. L.A. Care Health Plan designates this live course for a maximum of 3 AMA PRA Category 1 Credits™. L.A. Care Health Plan Provider Continuing Education Department maintains responsibility for this program and its content.
 
L.A. Care Health Plan is an approved Continuing Education Provider (CEP13731) by the California Board of Registered Nursing. This program is approved and live course meets the qualifications of 3 hours of continuing education credits for RNs and NPs as required by the California Board of Registered Nursing.
 

PLEASE NOTE THAT PARKING AT THE SAPC ALHAMBRA CAMPUS COSTS $3.00 PER VEHICLE. WE STRONGLY ENCOURAGE YOU TO CARPOOL. THIS LECTURE IS FREE BUT PRE-REGISTRATION IS REQUIRED.

Please contact Victoria Norith by phone (310) 267-5408 or e-mail (vnorith@mednet.ucla.edu) if you have questions, concerns, special needs, or require additional information before registering for this training
 
If you need a disability-related reasonable accommodation/alternative format for this event, please contact Shannon Bertea at (310) 267-5398, sbertea@mednet.ucla.edu by Friday, December 8th.

 

CLICK HERE TO REGISTER ONLINE

 

CLICK HERE FOR FLYER TO REGISTER BY MAIL

 

Hosted at A2